Cargando…
Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer
Cancer causes muscle mass loss, which is associated with a poor prognosis. Chemotherapy may also reduce muscle mass. We investigated skeletal muscle mass change during palliative chemotherapy for advanced gastric cancer (AGC) and its association with treatment outcomes. We retrospectively reviewed 1...
Autores principales: | Park, Song Ee, Choi, Jin Hwa, Park, Jae Yong, Kim, Beom Jin, Kim, Jae Gyu, Kim, Jong Won, Park, Joong-Min, Chi, Kyong-Choun, Hwang, In Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573603/ https://www.ncbi.nlm.nih.gov/pubmed/33077864 http://dx.doi.org/10.1038/s41598-020-74765-8 |
Ejemplares similares
-
Factors predicting outcomes of laparoscopic Nissen fundoplication for gastroesophageal reflux disease: experience at a single institution in Korea
por: Park, Joong-Min, et al.
Publicado: (2017) -
Unresectable gastric cancer with gastric outlet obstruction and distant metastasis responding to intraperitoneal and folfox chemotherapy after palliative laparoscopic gastrojejunostomy: report of a case
por: Park, Joong-Min, et al.
Publicado: (2010) -
Low PARP-1 expression level is an indicator of poor prognosis in patients with stage II and III gastric cancer
por: Park, Song Ee, et al.
Publicado: (2022) -
Risk factors and clinical outcomes of postgastrectomy sarcopenia newly developed after curative resection for gastric cancer
por: Kim, Hye Jin, et al.
Publicado: (2022) -
Clinical Implication of DNA Damage Response Genes in Advanced Gastric Cancer Stage IV and Recurrent Gastric Cancer Patients After Gastrectomy Treated Palliative Chemotherapy
por: Kim, Jeong Eun, et al.
Publicado: (2023)